These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 36430365)
21. Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease. Choi DY; Lee YJ; Hong JT; Lee HJ Brain Res Bull; 2012 Feb; 87(2-3):144-53. PubMed ID: 22155297 [TBL] [Abstract][Full Text] [Related]
22. Update on new trends and progress of natural active ingredients in the intervention of Alzheimer's disease, based on understanding of traditional Chinese and Western relevant theories: A review. Li W; Rang Y; Liu H; Liu C Phytother Res; 2023 Sep; 37(9):3744-3764. PubMed ID: 37380605 [TBL] [Abstract][Full Text] [Related]
23. Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics. Chakraborty S Curr Top Med Chem; 2017; 17(31):3336-3348. PubMed ID: 29345580 [TBL] [Abstract][Full Text] [Related]
24. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064 [TBL] [Abstract][Full Text] [Related]
25. Natural Polyphenols in the Treatment of Alzheimer's Disease. Syarifah-Noratiqah SB; Naina-Mohamed I; Zulfarina MS; Qodriyah HMS Curr Drug Targets; 2018; 19(8):927-937. PubMed ID: 28356027 [TBL] [Abstract][Full Text] [Related]
26. Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Pasinetti GM; Wang J; Ho L; Zhao W; Dubner L Biochim Biophys Acta; 2015 Jun; 1852(6):1202-8. PubMed ID: 25315300 [TBL] [Abstract][Full Text] [Related]
27. Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria. Schaffer S; Asseburg H; Kuntz S; Muller WE; Eckert GP Mol Neurobiol; 2012 Aug; 46(1):161-78. PubMed ID: 22706880 [TBL] [Abstract][Full Text] [Related]
28. Small Molecule Natural Products and Alzheimer's Disease. Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
30. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease. Savelieff MG; DeToma AS; Derrick JS; Lim MH Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056 [TBL] [Abstract][Full Text] [Related]
31. Natural Products Targeting Amyloid Beta in Alzheimer's Disease. Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858 [TBL] [Abstract][Full Text] [Related]
33. Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities. Yan L; Guo MS; Zhang Y; Yu L; Wu JM; Tang Y; Ai W; Zhu FD; Law BY; Chen Q; Yu CL; Wong VK; Li H; Li M; Zhou XG; Qin DL; Wu AG Oxid Med Cell Longev; 2022; 2022():5288698. PubMed ID: 35237381 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms. Dehghani R; Rahmani F; Rezaei N Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357 [TBL] [Abstract][Full Text] [Related]
35. Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease. Sadhukhan P; Saha S; Dutta S; Mahalanobish S; Sil PC Pharmacol Res; 2018 Mar; 129():100-114. PubMed ID: 29183770 [TBL] [Abstract][Full Text] [Related]
36. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease. Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Tonk S; Kuruva CS; Bhatti JS; Kandimalla R; Vijayan M; Kumar S; Wang R; Pradeepkiran JA; Ogunmokun G; Thamarai K; Quesada K; Boles A; Reddy AP J Alzheimers Dis; 2018; 61(3):843-866. PubMed ID: 29332042 [TBL] [Abstract][Full Text] [Related]
37. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease. Behl T; Kaur I; Fratila O; Brata R; Bungau S Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199 [TBL] [Abstract][Full Text] [Related]
38. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease? Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421 [TBL] [Abstract][Full Text] [Related]
39. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
40. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease. Paouri E; Tzara O; Zenelak S; Georgopoulos S J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]